16S rRNA gene sequencing reveals the correlation between the gut microbiota and the susceptibility to pathological scars
Frontiers in Microbiology · 20.06.2023 · 14
DOI: 10.3389/fmicb.2023.1215884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 20.06.2023. Verfasst von Ming Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery and Regenerative Medicine, Fujian Medical University Union Hospital, Fuzhou, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The gut microbiome profile in patients with pathological scars remains rarely known, especially those patients who are susceptible to pathological scars. Previous studies demonstrated that gut microbial dysbiosis can promote the development of a series of diseases via the interaction between gut microbiota and host. The current study aimed to explore the gut microbiota of patients who are prone to suffer from pathological scars. 35 patients with pathological scars (PS group) and 40 patients with normal scars (NS group) were recruited for collection of fecal samples to sequence the 16S ribosomal RNA (16S rRNA) V3-V4 region of gut microbiota. Alpha diversity of gut microbiota showed a significant difference between NS group and PS group, and beta diversity indicated that the composition of gut microbiota in NS and PS participants was different, which implied that dysbiosis exhibits in patients who are susceptible to pathological scars. Based on phylum, genus, species levels, we demonstrated that the changing in some gut microbiota ( Firmicutes; Bacteroides; Escherichia coli , etc.) may contribute to the occurrence or development of pathological scars. Moreover, the interaction network of gut microbiota in NS and PS group clearly revealed the different interaction model of each group. Our study has preliminary confirmed that dysbiosis exhibits in patients who are susceptible to pathological scars, and provide a new insight regarding the role of the gut microbiome in PS development and progression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic Surgery and Regenerative Medicine, Fujian Medical University Union Hospital, Fuzhou, China.
- Department of Plastic Surgery and Regenerative Medicine Institute, Fujian Medical University, Fuzhou, China.
- Engineering Research Center of Tissue and Organ Regeneration, Fujian Province University, Fuzhou, China.
- Nursing Department of Fujian Medical University Union Hospital, Fuzhou, China.
- Department of Dermatology, Pingtan Comprehensive Experimental Area Hospital, Fuzhou, China.
- Fuzhou MineButy Clinics, Fuzhou, China.
Zitieren
APA
Li, M., Li, M., Dai, Y., Li, D., Yu, H., Liu, J., Gao, H., Zhong, Y., Huang, M., Lin, J., Xie, Y., Guo, Z., & Chen, X. (2023). 16S rRNA gene sequencing reveals the correlation between the gut microbiota and the susceptibility to pathological scars. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1215884
Vancouver
Li M, Li M, Dai Y, Li D, Yu H, Liu J, et al. 16S rRNA gene sequencing reveals the correlation between the gut microbiota and the susceptibility to pathological scars. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1215884
BibTeX
@article{Li2023,
author = {Li, Ming and Li, Minghao and Dai, Yingting and Li, Dang and Yu, Han and Liu, Jian and Gao, Hangqi and Zhong, Yi and Huang, Mingquan and Lin, Jing and Xie, Yide and Guo, Zhihui and Chen, Xiaosong},
title = {16S rRNA gene sequencing reveals the correlation between the gut microbiota and the susceptibility to pathological scars},
journal = {Frontiers in Microbiology},
year = {2023},
volume = {14},
doi = {10.3389/fmicb.2023.1215884}
}
EUVIMED